Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat vs ESA in Anemia of CKD on Hemodialysis
NCT06901505Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Jul 2025
- Primary completion
- Aug 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Jul 2025; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT06901505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901505.